Short- and Long Term Antibacterial Effects of a Single Rinse With Different Mouthwashes: a Randomized Clinical Trial

Sponsor
Semmelweis University (Other)
Overall Status
Completed
CT.gov ID
NCT05178823
Collaborator
(none)
171
1
4
39
4.4

Study Details

Study Description

Brief Summary

Objectives: To reduce the microbial level in the aerosol created during dental procedures is essential in avoiding infections. The aim of this study was to examine the change of Streptococcus mutans (S. mutans) and the total bacterial load in human saliva in vivo after a single rinse with different mouthwashes.

Material and methods: One mL unstimulated saliva was collected from volunteers with poor oral hygiene at baseline and 5 min after a one-min rinsing with Solumium Oral® (hyper-pure 0.0015% chlorine dioxide; ClO2), Listerine Total Care®, Corsodyl® (0.2% chlorhexidine-digluconate; CHX), or BioGate Si*CLEAN for bacterial investigation. In a second study volunteers rinsed with 0.003% ClO2 or CHX for one-min and saliva was collected at baseline, after 5 and 90 min. After plating the total plate and S. mutans colony numbers were determined.

Condition or Disease Intervention/Treatment Phase
  • Drug: Chlorhexidine mouthwash
Phase 4

Detailed Description

Sample and procedure In the first study we collected 1 mL of unstimulated whole saliva by spitting participants into a sterile Eppendorf tube at baseline and 5 min after rinsing with 5 mL of 4 different types of commercially available mouthwashes from identical opaque-coded flasks. From our clinical ambulance randomly selected 145 patients assessed for eligibility.

Inclusion criteria were: DMF≥10, minimum 5 active caries and PSR≥2. Exclusion criteria were:

smoking, a history of antibiotic, or probiotic use 3 months prior to sampling, or known allergy to any of the ingredients of mouthwashes being tested. Twenty five patients were excluded (19 of these based on the criteria above and 6 refused to participate). One hundred and twenty volunteering patients (42±8 years) with poor oral hygiene were selected to participate in the study. All eligible subjects were given oral and written information about the products and the purpose of the study and were asked to sign an informed consent form. Volunteers were randomly assigned to the tests and the positive control (Corsodyl®) groups. Randomization was performed using computer-generated random numbers. The randomization and the allocation of rinse aids were carried out by a person not directly involved in the research project. The volunteers rinsed for 1 min, with a 20-fold dilution of hyper-pure 0.03 % ClO2 (Solumium Oral®, final concentration: 0.0015%), Corsodyl® (0.2% CHX), Listerine Total Care® (essential oils, sodium fluoride, zinc chloride), or BioGate Si*CLEAN® (microsilver) (30 individuals in each mouthwash group).

In the second study randomly chosen 26 medical student volunteers (20±3 years) rinsed with 5 mL of 10-fold diluted hyper-pure ClO2 (final concentration: 0.003%) or Corsodyl® for 1 min, and their unstimulated whole saliva was collected as above at base line and after 5 and 90 minutes (13 individuals in each mouthwash group). The restrictions on the oral hygiene of the volunteers were: DMF≥5, minimum 1 active caries, PSR≥1 and exclusion categories were the same as in the first study. The management of eligible subjects, their randomization and the allocation of rinse aids in same opaque-coded flasks were also exactly identical to the first study. Eleven volunteers were excluded from this study (9 of these based on the criteria above and 2 refused to participate).

The saliva samples were stored in Eppendorf tubes used for collection at air-conditioned room temperature and processed within two hours. A dilution series was prepared from the samples in physiological salt solution. To determine our pre-specified primary outcome, the total bacterial count and the S. mutans number (CFU/ml) blood and Mitis-Salivarius (Difco, Becton-Dickinson, Hungary) agars were inoculated, respectively. Cultivation was carried out at 37 °C, 5 % CO2 and took 2 days. The CFU counting researcher did not know which plates were exposed to each treatment.

Study Design

Study Type:
Interventional
Actual Enrollment :
171 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Prevention
Official Title:
Short- and Long Term Antibacterial Effects of a Single Rinse With Different Mouthwashes: a Randomized Clinical Trial
Actual Study Start Date :
Jun 1, 2017
Actual Primary Completion Date :
Sep 1, 2019
Actual Study Completion Date :
Sep 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Corsodyl

Chlorhexidine

Drug: Chlorhexidine mouthwash
Comparison of oral rinses
Other Names:
  • chlorine dioxide
  • essential oils, sodium fluoride, zinc chloride
  • microsilver
  • Experimental: Solumium Oral

    Chlorine dioxide

    Drug: Chlorhexidine mouthwash
    Comparison of oral rinses
    Other Names:
  • chlorine dioxide
  • essential oils, sodium fluoride, zinc chloride
  • microsilver
  • Experimental: Listerine Total Care

    Essential oils, sodium fluoride, zinc chloride

    Drug: Chlorhexidine mouthwash
    Comparison of oral rinses
    Other Names:
  • chlorine dioxide
  • essential oils, sodium fluoride, zinc chloride
  • microsilver
  • Experimental: BioGate Si*CLEAN

    Microsilver

    Drug: Chlorhexidine mouthwash
    Comparison of oral rinses
    Other Names:
  • chlorine dioxide
  • essential oils, sodium fluoride, zinc chloride
  • microsilver
  • Outcome Measures

    Primary Outcome Measures

    1. Salivary bacterial CFU/mL [1 or 90 min after rinsing]

      Salivary bacterial CFU/mL

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • DMF≥10,

    • minimum 5 active caries

    • PSR≥2

    Exclusion Criteria:
    • smoking,

    • a history of antibiotic, or probiotic use 3 months prior to sampling

    • known allergy to any of the ingredients of mouthwashes being tested

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Semmelweis University Budapest Hungary 1088

    Sponsors and Collaborators

    • Semmelweis University

    Investigators

    • Principal Investigator: Zsolt Lohinai, PHD, Semmelweis University, Department of Conservative Dentistry

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Semmelweis University
    ClinicalTrials.gov Identifier:
    NCT05178823
    Other Study ID Numbers:
    • Solumium
    First Posted:
    Jan 5, 2022
    Last Update Posted:
    Feb 24, 2022
    Last Verified:
    Feb 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Semmelweis University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 24, 2022